Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Colin P.N. Dinney"'
Autor:
Wei Qiao, Colin P.N. Dinney, Vikram M. Narayan, Amy Lim, Neema Navai, Roger Li, Hyunsoo Hwang, Mohamed Seif
Publikováno v:
Journal of Clinical Oncology. 37:490-490
490 Background: Radical cystectomy (RC) is the standard of care for non-metastatic, muscle invasive bladder cancer. Studies comparing robotic to open RC have found that the robotic approach confers non-inferior oncologic outcomes while potentially de
Autor:
Colin P.N. Dinney, Peter F. Thall, H. Barton Grossman, Dallas Williams, Wei Qiao, Ashish M. Kamat, Randall E. Millikan, Arlene O. Siefker-Radtke
Publikováno v:
Journal of Clinical Oncology. 27:2592-2597
Purpose Currently, treatment recommendations for small-cell urothelial cancer (SCUC) are based on anecdotal case reports and small retrospective series. We now report results from the first phase II clinical trial developed exclusively for SCUC, to o
Autor:
Denise Woods, James A. Merritt, Paul Perrotte, Joel W. Slaton, H. Barton Grossman, Lance C. Pagliaro, Afsaneh Keyhani, Colin P.N. Dinney, Dallas Williams, Baoshun Liu
Publikováno v:
Journal of Clinical Oncology. 21:2247-2253
Purpose: We investigated the feasibility, safety, and biologic activity of adenovirus-mediated p53 gene transfer in patients with locally advanced bladder cancer. Patients and Methods: Patients with measurable, locally advanced transitional-cell carc
Autor:
Jay B. Shah, Ashish M. Kamat, Courtney M Chang, Colin P.N. Dinney, Janet Baack Kukreja, Neema Navai, Mohamed Seif
Publikováno v:
Journal of Clinical Oncology. 35:311-311
311 Background: Bupivacaine liposome injectable suspension (LB) can be used to help control postoperative pain. It slowly releases bupivacaine for up to 96 hours after injection. This study sought to determine if the use of LB intraoperatively for ra
Autor:
Janet Baack Kukreja, Xuemei Wang, Hsiang-Chun Chen, Jason M Podolnick, Colin P.N. Dinney, Jay B. Shah, Neema Navai, Ashish M. Kamat
Publikováno v:
Journal of Clinical Oncology. 35:352-352
352 Background: Pre-operative neutrophil-to-lymphocyte ratio (NLR) has been found to be associated with adverse pathological results and poor long-term outcomes in patients treated with radical cystectomy (RC) for urothelial bladder carcinoma (BC). P
Autor:
Colin P.N. Dinney, Ting-Yu Chen, Courtney M Chang, Ashish M. Kamat, Xin Shelley Wang, Neema Navai, Janet Baack Kukreja, Qiuling Shi, Jay B. Shah
Publikováno v:
Journal of Clinical Oncology. 35:340-340
340 Background: Bladder cancer is a disease of the elderly associated with high morbidity in those undergoing radical cystectomy (RC). The Optimized Surgical Journey (OSJ) uses enhanced recovery after surgery (ERAS) principles for RC patients to impr
Autor:
Neema Navai, Ashish M. Kamat, Lianchun Xiao, Michael J. Metcalfe, James E. Ferguson, Colin P.N. Dinney, Roger Li, Jay B. Shah
Publikováno v:
Journal of Clinical Oncology. 35:366-366
366 Background: In muscle invasive bladder cancer there is an increased risk for systemic disease identified for patients with certain high risk features (HRF): pre-operative hydronephrosis (POH), lymphovascular invasion (LVI), abnormal exam under an
Autor:
Xuemei Wang, Colin P.N. Dinney, Janet Baack Kukreja, Hsiang-Chun Chen, Jay B. Shah, Neema Navai, Jason M Podolnick, Ashish M. Kamat
Publikováno v:
Journal of Clinical Oncology. 35:324-324
324 Background: There is growing interest in finding inexpensive, easily reproducible biomarkers to predict outcomes in patients with urothelial bladder carcinoma (BC). An elevated preoperative neutrophil-to-lymphocyte Ratio (NLR) has been found to b
Autor:
Jae Y. Ro, Christopher J. Logothetis, Paul Sweeney, Colin P.N. Dinney, Dallas Williams, David A. Swanson, Terry L. Smith, Randall E. Millikan
Publikováno v:
Journal of Clinical Oncology. 19:4005-4013
PURPOSE: We conducted a phase III trial to investigate the timing of chemotherapy with respect to surgery for patients with resectable but high-risk urothelial cancer. The trial was also designed to evaluate the accuracy of clinical staging in patien
Autor:
Colin P.N. Dinney, Curtis A. Pettaway, H. Barton Grossman, Surena F. Matin, Neema Navai, William F. Graber, Brian F. Chapin, Ashish M. Kamat, Andrew Mount, Stephen B. Williams
Publikováno v:
Journal of Clinical Oncology. 34:378-378
378 Background: Fluorescence cystoscopy (also known as blue-light cystoscopy (BL)) is an adjunct to white light cystoscopy (WL) and aids in visualization of tumors that may be missed with WL as well as allow more complete resection of tumors. Herein